Substance use disorder is associated with a higher risk for COVID-19 than that seen in the general population, as well as worse outcomes.
Considering the impact quarantine has on resources and individual liberty, it is important to evaluate under what conditions individual quarantine can more effectively control COVID-19 than active monitoring.
Researchers evaluated the possibility of SARS-CoV-2 infection accelerating the onset of an autoimmune rheumatic disease.
The ACTT-2 study began on May 8 and included more than 1000 patients.
Patients treated with tocilizumab were 44% less likely to progress to mechanical ventilation or death compared with placebo.
A case of COVID-19 transmission in a high-rise apartment complex in China demonstrates the probable transmission of SARS-CoV-2 through fecal aerosols.
Single-dose nirsevimab successfully reduced rates of respiratory syncytial virus-associated lower respiratory infections and hospitalizations in pre-term infants.
In expanded research, investigators studied the effects of therapeutic and prophylactic anticoagulation treatment in hospitalized patients with COVID-19.
In March 2020 there was an 80-fold increase in new prescriptions for hydroxychloroquine compared with March 2019.
People with asthma were not overrepresented in patients with severe pneumonia because of SARS-CoV-2 infection who required hospitalization.
Expired or previously used and sterilized N95 respirators can be used when new N95 respirators are unavailable during the COVID-19 pandemic.
Preliminary evidence suggests infants are unlikely to become infected with SARS-CoV-2 via breast milk.
Nursing home staff will have to be tested regularly for COVID-19, and facilities that fail to do so will face fines.
An investigational inactivated whole-virus COVID-19 vaccine has demonstrated safety and immunogenicity, according to an interim analysis.
Influenza vaccinations were found to be underutilized among groups who are considered to be at high risk for complications from infection.
Results are provided within 15 minutes and can be read directly from the testing card.
Clinicians must consider patient sexual history in the decision-making process for adult HPV vaccination.
Previously, the EUA limited use to patients with severe COVID-19 disease.
Men with severe hair loss were significantly more likely to test positive for COVID-19, finds study data.
Many hospital nurses in Illinois and New York were burned out and working in understaffed conditions immediately prior to the pandemic.